Bio-Gene Technology

Bio-Gene Technology Depreciation & Amortization

The Depreciation & Amortization of Bio-Gene Technology (BGT.AX) as of Oct 25, 2026 is 41,900.00 AUD. In the previous year, Depreciation & Amortization was 38,400.00 AUD — a change of 9.11% (higher).

Depreciation & Amortization

41,900.00AUD

YoY

9.11%

Last updated:

Depreciation & Amortization of Bio-Gene Technology is 2025 41,900.00 AUD. Depreciation & Amortization of Bio-Gene Technology was 2024 38,400.00 AUD. It decreases by 9.11% higher compared to the previous year.

The Bio-Gene Technology Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2018
42,000.00 AUD
Jan 1, 2019
45,600.00 AUD
Jan 1, 2020
58,400.00 AUD
Jan 1, 2021
54,200.00 AUD
Jan 1, 2022
43,500.00 AUD
Jan 1, 2023
45,300.00 AUD
Jan 1, 2024
38,400.00 AUD
Jan 1, 2025
41,900.00 AUD
The Bio-Gene Technology Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
41,900.00AUD+9.11%
38,400.00AUD-15.23%
45,300.00AUD+4.14%
43,500.00AUD-19.74%
54,200.00AUD-7.19%
58,400.00AUD+28.07%
45,600.00AUD+8.57%
42,000.00AUD+5.53%
39,800.00AUD+151.90%
15,800.00AUD+56.44%
10,100.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-Gene Technology Stock analysis

What does Bio-Gene Technology do? Bio-Gene Technology Ltd develops and commercializes insecticides using beta-triketone platform technology. The company's lead products are Flavocide, a chemically synthesized insecticide based on flavesone, and Qcide, a natural oil product containing tasmanone extracted from Gympie Messmate leaves via steam distillation. These products address insecticide resistance and toxicity issues in crop protection, storage, public health, animal health, and consumer applications. Insecticide manufacturers purchase the company's platform technology and products for commercialization across multiple sectors. The firm's beta-triketone platform provides multiple solutions for insecticide manufacturers seeking to develop novel pest control products. Flavocide and Qcide represent the company's primary commercial offerings, with Flavocide targeting synthetic insecticide markets and Qcide focusing on natural oil-based solutions. The company's technology enables the development of targeted insect control solutions for various applications including agricultural crop protection and public health management. Bio-Gene Technology Ltd. aims to develop a portfolio of targeted insect control solutions for insecticide manufacturers. The company's platform technology allows manufacturers to create new products addressing resistance and toxicity challenges. Through its two lead products, the company provides both synthetic and natural options for the insecticide market, targeting manufacturers who seek innovative solutions for pest management across different industry segments. Bio-Gene Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-Gene Technology stock

Depreciation & Amortization of Bio-Gene Technology is 41,900.00 AUD in 2025.

Depreciation & Amortization of Bio-Gene Technology changed from 38,400.00 AUD to 41,900.00 AUD, representing a 9.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Depreciation & Amortization Bio-Gene Technology since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Bio-Gene Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bio-Gene Technology

All Key Metrics — Bio-Gene Technology